Wooly Mammoth startup Colossal seeking at least $20B valuation
De-extinction startup Colossal Biosciences is in talks to raise new capital with a target valuation between $20 billion and $30 billion.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Colossal Biosciences, a startup focused on de-extinction and the wooly mammoth, is reportedly seeking a new funding round. The company is discussing a valuation of at least $20 billion, with some reports suggesting it could reach $30 billion.
Coverage from TechCrunch, Axios, Seeking Alpha, Zamin.uz, and Межа. Новини України emphasizes the scale of the capital raise and the specific valuation targets being discussed. The reports characterize the company as a de-extinction startup.
Future developments depend on the outcome of these funding discussions and whether the company secures the reported valuation.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 6h ago.
Quick answers
What is Colossal Biosciences' target valuation?
The company is seeking a valuation of at least $20 billion, with reports indicating it could be between $20 billion and $30 billion.
What is the primary focus of the company?
Colossal Biosciences is described as a de-extinction startup, specifically associated with the wooly mammoth.
Who is reporting on this funding round?
The news is being reported by outlets including TechCrunch, Axios, Seeking Alpha, Zamin.uz, and Межа. Новини України.
Coverage (5)
- Colossal Biosciences seeks 20 to 30 billion valuation in new funding round Межа. Новини України. · 20h ago
- Colossal Biosciences, the de-extinction startup, could reach a $30 billion valuation Zamin.uz · 20h ago
- Colossal Biosciences discussing new funding at $20B or more valuation: report (IBB:NASDAQ) Seeking Alpha · 20h ago
- Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation TechCrunch · 20h ago
- Wooly Mammoth startup Colossal seeking at least $20B valuation Axios · 20h ago
Topics
Related trends
'We're paranoid.' As China biotech competition heats up, American drugmakers get more secretive
6 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
AI Training Startup Mercor Discusses $20 Billion Valuation
AI data labeling startup Mercor is in discussions to secure a $20 billion valuation following reports of substantial revenue growth.
AI chip maker SambaNova raises $1B at $11B valuation, 5 months after last mega round
AI chip startup SambaNova has secured $1 billion in new funding, reaching an $11 billion valuation just five months after its previous mega round.
Bezos' Blue Origin valued at $130 billion in first public fundraising round
4 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Blue Origin, for the first time, is expected to raise private capital
Blue Origin is seeking its first outside funding round, with a reported valuation of $130 billion.
“Televised Nervous Breakdown”: CEO of Palantir Suffers a Bit of a Meltdown During Live Interview
Palantir CEO Alex Karp's public outburst against AI labs has sparked widespread coverage and debate.